#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Partial lipodystrophy Osteosarcoma recurrent Primary immunodeficiency syndrome Solitary fibrous tumour Gastrointestinal stromal tumour Crohn's disease IgA nephropathy Cerebral arteriovenous malformation haemorrhagic Hidradenitis Warm autoimmune haemolytic anaemia Cutaneous T-cell lymphoma stage I Transitional cell cancer of the renal pelvis and ureter Adenocarcinoma gastric Chorioretinitis Granulomatosis with polyangiitis More trials…

    Learn about Rare Diseases

    Hereditary neuropathic amyloidosis – Diagnostics Systemic sclerosis pulmonary – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Hereditary motor and sensory neuropathy Basal cell naevus syndrome – Diagnostics IgA nephropathy – Diagnostics Isodicentric chromosome 15 syndrome Waldenstrom’s macroglobulinaemia refractory – Treatment Mucopolysaccharidosis II – Treatment Immunodeficiency congenital – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Basiliximab Zoledronic Acid Paclitaxel Albumin-Bound Indometacin Ph. Eur. AGA2118 Maridebart Cafraglutide Rebisufligene Etisparvovec ARI0008 Dapagliflozin Cldn6 Rna-Lpx Varnimcabtagene Autoleucel VHB937 Adezunap Botaretigene Sparoparvovec Dasatinib Holcus Lanatus Pollen Extract RO7288817 64Cu-Dota-Ae105 AMO959 Olorofim More therapies…

    Learn about Your Condition

    Tertiary adrenal insufficiency Haematological malignancy Retinopathy proliferative COVID-19 Hypoparathyroidism Oedema peripheral Rheumatoid arthritis Obstructive pancreatitis Oesophageal carcinoma Ulcerative keratitis Ophthalmoplegia Neonatal respiratory failure Laparoscopic surgery Large cell lung cancer Spinal muscular atrophy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of LY3537982 for Patients with Advanced Solid Tumors with KRAS G12C Mutation

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • 2-AMINO-4-[(4AS)-8-CHLORO-10-FLUORO-2,3,4,4A,5,6-HEXAHYDRO-12-OXO-3-(1-OXO-2-PROPEN-1-YL)-1H,12H-PYRAZINO[2,1-D][1,5]BENZOXAZOCIN-9-YL]-7-FLUORO-BENZO[B]THIOPHENE-3-CARBONITRILE
    • Ly3537982
    • Cetuximab
    France

  • Study of Axitinib and Etoposide for Children and Young Adults with Refractory or Relapsing Medulloblastoma and Ependymoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Ependymoma malignant
    • Medulloblastoma recurrent
    Investigated Drugs:
    • Axitinib
    • Etoposide
    France

  • Long-Term Safety and Efficacy Study of Mexiletine Hydrochloride for Patients with Myotonic Dystrophy Type 1 and Type 2

    Recruiting

    3 1 1
    Investigated Drugs:
    • Mexiletine Hydrochloride
    Belgium Denmark Germany Italy Spain

  • Study on VE303 for Preventing Recurrent C. difficile Infection in Patients

    Recruiting

    3 1
    Investigated Diseases:
    • Clostridium difficile infection
    Investigated Drugs:
    • Bacilli, Cluster Xvii, Strain Relative Clostridium_Aq Innocuum, Live
    • Clostridia, Cluster Xiva, Strain Relative Blautia Sp001304935, Live
    • Clostridia, Cluster Xiva, Strain Relative Dorea_A Longicatena, Live
    Belgium Bulgaria Czechia Denmark France Germany +8

  • Study on the Effects of Landiolol Hydrochloride for Patients with Microcirculatory Issues During Septic Shock

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Landiolol Hydrochloride
    France

  • Study of Cemiplimab, Carboplatin, and Paclitaxel for Adults with Operable Non-Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Regn7075
    • Carboplatin
    • Cemiplimab
    France Germany Spain
Previous Page
1 … 394 395 396 397 398 … 1,651
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!